Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms

Inclusion Criteria: * Patient received kidney transplant at least 1 month prior to study with MMF as a part of the treatment for at least 2 weeks. * Eligible to convert to myfortic because of GI complaints or not currently experiencing GI complaints and stable on current immunosuppressive regimen. * At least 18 years of age; * Willing to provide written informed consent; and * Able to meet all study requirements including completing paper questionnaires and completing two study visits. Exclusion Criteria: * GI symptoms assumed or known not be caused by MPA therapy and have recent acute rejection at least 1 week prior to the study. * Breast-feeding or pregnant woman. * Patients with psychiatric illness. * Underlying acute medical intervention or hospitalization * Receiving investigational drug within 30days prior to study.